Previous 10 | Next 10 |
Rite Aid's turnaround plan revolves around enhancing the in-store customer experience, which previous company executives and other retailers have already tried and failed. The income statement is plagued by unusual, non-recurring impairment and restructuring charges that cloud the pic...
Through its partnership with the U.S. Department of Health and Human Services, Rite Aid ([[RAD]] +0.3%) is further expanding its no-charge COVID-19 testing capabilities with 99 additional drive-through locations opening on Dec. 22.Self-swab testing capacity increased by more than 30...
Self-Swab Testing Capacity Increased by More Than 30% Rite Aid (NYSE: RAD) is further expanding its no-charge COVID-19 testing capabilities with 99 additional drive-through locations opening on Tuesday, December 22 through its partnership with the U.S. Department of Health a...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Tesla makes grand entrance into S&P 500Index funds tracking the S&P 500 have a small window today to buy nearly $80B worth of Tesla (TSLA) stock as...
Rite Aid (NYSE: RAD) did its shareholders right on Thursday by delivering a far-better-than-expected third quarter of fiscal 2021. The big pharmacy operator published the results of the quarter this morning, and they revealed a 12% year-over-year jump in revenue to $6.1 billion....
Rite Aid Corporation (RAD) Q3 2021 Earnings Conference Call December 17, 2020 8:30 AM ET Company Participants Trent Kruse - VP of IR and Treasury Heyward Donigan - CEO Jim Peters - COO Dan Robson - President, EnvisionRxOptions Matt Schroeder - CFO Conference Call Participants Lisa Gill - JPMo...
Shares of Rite Aid (NYSE: RAD) were soaring 22.1% higher as of 10:53 a.m. EST on Thursday. The big jump came after the pharmacy company announced its fiscal 2021 third-quarter results before the market opened. Rite Aid reported revenue of $6.1 billion, up 12% year over year. The...
Gainers: Vivos Therapeutics (VVOS) +51%, Jupiter Wellness (JUPW) +21%, Evolus (EOLS) +27%, PainReform (PRFX) +24%, Rite Aid (RAD) +23%.Losers: BioCardia (BCDA) -23%, SCYNEXIS (SCYX) -19%, Zynerba Pharmaceuticals (ZYNE) -15%, Han...
Rite Aid ([[RAD]] +23.2%) reports Q3 results:Revenue of $6.12B (+12.1% Y/Y).vs. consensus of $5.84B, driven by growth in both Retail Pharmacy and Pharmacy Services segments.Retail Pharmacy revenue +5.1% to $4.11B and Pharmacy Services revenue +29.2% to $2.08B.Net income from co...
Takung Art (TKAT) +81%.Evolus (EOLS) +43% after company updates on U.S. ITC case related to Jeuveau sales and marketing.Skillful Craftsman Education Technology (EDTK) +17%.Marathon Patent Group (MARA) +23%.Rite Aid Corporation (RAD) +21% on Q3 results.Vivos Therapeuti...
News, Short Squeeze, Breakout and More Instantly...
Secures Interim Approval to Access Up to $3.45 Billion in Debtor-in-Possession Financing Continues to Serve Customers and Deliver Healthcare Products and Services Across Retail and Online Platforms Rite Aid Corporation (OTC: RADCQ) (“Rite Aid” or the “Compan...
Stein Succeeds Elizabeth “Busy” Burr Rite Aid Corporation (NYSE: RAD) (“Rite Aid” or the “Company”) today announced that its Board of Directors has appointed Jeffrey S. Stein as Chief Executive Officer (CEO), Chief Restructuring Officer (CRO) an...
Reaches Agreement in Principle with Key Creditors on the Terms of Financial Restructuring Plan Initiates Voluntary Chapter 11 Process to Implement a Consensual Financial Restructuring That Will Significantly Reduce Debt and Enable Execution of Key Initiatives Receives Commitment f...